GSK

News

UK adds chickenpox to childhood vaccination schedule

The UK will offer free vaccination against chickenpox to young children from the start of 2026, in the hope of eliminating cases in a couple of years.

News

Dynavax has GSK's shingles vaccine in its sights

Big pharma group GSK has been ruling the market for shingles vaccines for many years, but little Dynavax wants to knock off its crown.

News

Iterum brings first oral penem antibiotic to US market

Iterum has launched Orlynvah as a treatment for uncomplicated urinary tract infections (uUTIs), the first oral option in the go-to penem class.

News

FDA starts swift review of GSK antibiotic for gonorrhoea

An oral alternative to injectable treatment for uncomplicated gonorrhoea could be on the way in the US, as FDA starts review of GSK's gepotidacin.

News

GSK and CureVac settle mRNA patent spat with Pfizer/BioNTech

BioNTech's takeover of CureVac seems to have unlocked a resolution to some of the patent litigation swirling around mRNA vaccine technologies.

News

UK starts 'world-first' gonorrhoea vaccination push

The UK has started a gonorrhoea vaccination programme designed to prevent thousands of infections and save the NHS millions of pounds.

UK adds chickenpox to childhood vaccination schedule

Dynavax has GSK's shingles vaccine in its sights

Iterum brings first oral penem antibiotic to US market

FDA starts swift review of GSK antibiotic for gonorrhoea

GSK and CureVac settle mRNA patent spat with Pfizer/BioNTech

UK starts 'world-first' gonorrhoea vaccination push

Allogeneic cell therapy isn’t dead, with Brian Culley

How to meet your physicians where they are online

GSK

Editor's Picks